Atai Beckley Inc.
NASDAQ: ATAI0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Christian Angermayer
- Employees
- 99
- Headquarters
- New York, United States
- IPO year
- 2021
- Market cap
- $1.5B
- Website
- https://www.ataibeckley.com
Loading ATAI…
Loading profile data…Frequently asked questions about ATAI
What does Atai Beckley Inc. (ATAI) do?
Atai Beckley Inc. operates as a clinical-stage biopharmaceutical firm dedicated to the discovery, advancement, and commercialization of innovative therapeutic solutions for a variety of mental health conditions. The company's operations extend across the United States, Germany, and Canada. Its development pipeline features several key compounds:...
Where does ATAI trade?
Atai Beckley Inc. (ATAI) trades on the NASDAQ Global Market.
What sector is ATAI in?
Atai Beckley Inc. (ATAI) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Atai Beckley Inc.?
Christian Angermayer is the chief executive officer of Atai Beckley Inc. (ATAI).
Where is Atai Beckley Inc. headquartered?
Atai Beckley Inc. is headquartered in United States.
Does ATAI pay a dividend?
Atai Beckley Inc. (ATAI) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ATAI go public?
Atai Beckley Inc. (ATAI) completed its initial public offering in 2021.